Home
About
Overview
Sharing Data
ORCID
Help
History (68)
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial.
Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism.
Diffusion-tensor imaging in septo-optic dysplasia.
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.
See All 68 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.
Morrison TG, Walsh EE. Subunit and virus-like particle vaccine approaches for respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:285-306.
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Child, Preschool
Host Specificity
Humans
Infant
Mice
Nanoparticles
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus Vaccines
Respiratory Syncytial Virus, Human
Vaccines, Subunit
Vaccines, Virosome
Vaccines, Virus-Like Particle
Virosomes
authors with profiles
Trudy G Morrison PhD